Scientists fighting over the correct approach to assessing the risks from endocrine disrupting chemicals (EDCs) seem to have found some common ground at a meeting chaired by the European Commission’s chief scientist last month.
But the commission’s work on EDCs is still behind schedule with a paper on their authorisation under REACH, expected this week, unlikely to emerge.
It is also unclear when criteria for defining EDCs under the EU’s pesticide and biocide rules, which are due in mid-December, will be finalised.
Please enter your details
Not a subscriber?
Take a free trial now to discover the critical insights and updates our coverage offers subscribers.